Figure 3From: Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogenetics Overall survival by treatment arm and by geographic region (2010 mature analysis data set). (A) Decitabine arm; (B) Treatment choice [TC] arm.Back to article page